Cisatracurium besylate injection, is a nondepolarizing neuromuscular blocker indicated:
· as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age (1)
· to provide skeletal muscle relaxation during surgery in adults and in pediatric patients 2 to 12 years of age as a bolus or infusion
maintenance (1)
· for mechanical ventilation in the ICU in adults (1)